A Seattle doctor specializing in end-of-life care filed a formal petition with the U.S. Drug Enforcement Administration (DEA) this week challenging the government’s Schedule I classification of psilocybin, the main psychoactive component of psychedelic mushrooms. The petition, dated Tuesday, requests the agency to reschedule psilocybin as a less-restricted Schedule II drug, pointing to its relatively … Continue reading Seattle Doctor Files DEA Petition To Reschedule Psilocybin For Medical Use